USD 0.09
(10.97%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | -976 Thousand USD | 72.14% |
2023 | -3.5 Million USD | -0.89% |
2022 | -3.33 Million USD | -52.28% |
2021 | -2.28 Million USD | 23.82% |
2020 | -1.26 Million USD | -276.01% |
2019 | 1.15 Million USD | -1273.73% |
2018 | 67.81 Thousand USD | 105.07% |
2017 | -1.08 Million USD | 3.16% |
2016 | -1.16 Million USD | -101.05% |
2015 | -621.43 Thousand USD | -273.69% |
2014 | 364.24 Thousand USD | -40.05% |
2013 | 683.27 Thousand USD | 34.09% |
2012 | 520.76 Thousand USD | -56.88% |
2011 | 1.16 Million USD | -22.59% |
2010 | 1.5 Million USD | 26.11% |
2009 | 1.14 Million USD | 152.21% |
2008 | -8.82 Million USD | -1126.22% |
2007 | 250.52 Thousand USD | -63.17% |
2006 | 657.56 Thousand USD | -62.89% |
2005 | 1.62 Million USD | -13.5% |
2004 | 1.85 Million USD | 223.01% |
2003 | 582.2 Thousand USD | -51.9% |
2002 | 1.2 Million USD | -1.75% |
2001 | 1.23 Million USD | 36.54% |
2000 | 919.12 Thousand USD | -50.85% |
1999 | 1.9 Million USD | 38.46% |
1998 | 1.4 Million USD | 225.0% |
1997 | 900 Thousand USD | -55.56% |
1996 | 400 Thousand USD | 200.0% |
1995 | 500 Thousand USD | 133.33% |
1994 | -400 Thousand USD | -1000.0% |
1993 | 300 Thousand USD | -88.89% |
1992 | 800 Thousand USD | 80.0% |
1991 | 500 Thousand USD | -28.57% |
1990 | 700 Thousand USD | -22.22% |
1989 | 900 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -240 Thousand USD | 104.01% |
2024 Q3 | -239.7 Thousand USD | 57.99% |
2024 Q4 | -559 Thousand USD | -2.89% |
2024 Q2 | -570.54 Thousand USD | -805.57% |
2023 Q1 | -131.25 Thousand USD | 88.9% |
2023 FY | - USD | -0.89% |
2023 Q2 | -460.25 Thousand USD | -250.65% |
2023 Q3 | -1.22 Million USD | -165.51% |
2023 Q4 | -2.01 Million USD | -64.89% |
2022 FY | - USD | -52.28% |
2022 Q1 | 881.14 Thousand USD | 147.58% |
2022 Q2 | -1.04 Million USD | -218.31% |
2022 Q3 | -1.08 Million USD | -3.6% |
2022 Q4 | -1.18 Million USD | -9.44% |
2021 FY | - USD | 23.82% |
2021 Q1 | 87.68 Thousand USD | 103.94% |
2021 Q2 | -224.28 Thousand USD | -355.78% |
2021 Q3 | 586.41 Thousand USD | 361.46% |
2021 Q4 | -1.85 Million USD | -415.82% |
2020 Q3 | -531.8 Thousand USD | -1561.9% |
2020 Q1 | 657.81 Thousand USD | 292.91% |
2020 Q2 | -32 Thousand USD | -104.86% |
2020 FY | - USD | -276.01% |
2020 Q4 | -2.22 Million USD | -318.76% |
2019 Q3 | -413 Thousand USD | -235.18% |
2019 Q4 | -341 Thousand USD | 17.43% |
2019 FY | - USD | -1273.73% |
2019 Q1 | 816.3 Thousand USD | 832.16% |
2019 Q2 | 305.52 Thousand USD | -62.57% |
2018 Q3 | -692.98 Thousand USD | -255.25% |
2018 Q4 | -111.49 Thousand USD | 83.91% |
2018 FY | - USD | 105.07% |
2018 Q1 | 403.94 Thousand USD | 180.18% |
2018 Q2 | 446.35 Thousand USD | 10.5% |
2017 FY | - USD | 3.16% |
2017 Q4 | -503.78 Thousand USD | 25.75% |
2017 Q3 | -678.48 Thousand USD | -3415.33% |
2017 Q1 | -174.55 Thousand USD | 83.77% |
2017 Q2 | 20.46 Thousand USD | 111.72% |
2016 FY | - USD | -101.05% |
2016 Q4 | -1.07 Million USD | -255.31% |
2016 Q3 | -302.69 Thousand USD | -1040.81% |
2016 Q2 | 32.17 Thousand USD | 194.75% |
2016 Q1 | -33.95 Thousand USD | 95.61% |
2015 Q3 | -87.42 Thousand USD | -141.4% |
2015 FY | - USD | -273.69% |
2015 Q1 | 257.27 Thousand USD | 66.44% |
2015 Q2 | 211.15 Thousand USD | -17.92% |
2015 Q4 | -772.79 Thousand USD | -783.96% |
2014 Q3 | -25.49 Thousand USD | -110.74% |
2014 FY | - USD | -40.05% |
2014 Q4 | 154.57 Thousand USD | 706.35% |
2014 Q1 | 28.68 Thousand USD | -46.11% |
2014 Q2 | 237.39 Thousand USD | 727.58% |
2013 FY | - USD | 34.09% |
2013 Q4 | 53.23 Thousand USD | -48.97% |
2013 Q3 | 104.31 Thousand USD | -73.62% |
2013 Q2 | 395.45 Thousand USD | 272.6% |
2013 Q1 | 106.13 Thousand USD | -59.48% |
2012 Q3 | -72.84 Thousand USD | -130.31% |
2012 Q4 | 261.94 Thousand USD | 459.61% |
2012 FY | - USD | -56.88% |
2012 Q1 | 62.1 Thousand USD | -76.71% |
2012 Q2 | 240.35 Thousand USD | 287.05% |
2011 Q1 | 207.13 Thousand USD | -21.44% |
2011 Q2 | 293.52 Thousand USD | 41.71% |
2011 Q4 | 266.61 Thousand USD | -28.46% |
2011 Q3 | 372.7 Thousand USD | 26.98% |
2011 FY | - USD | -22.59% |
2010 Q1 | 345.46 Thousand USD | 12.04% |
2010 Q3 | 341.59 Thousand USD | -34.55% |
2010 Q4 | 263.66 Thousand USD | -22.81% |
2010 Q2 | 521.9 Thousand USD | 51.07% |
2010 FY | - USD | 26.11% |
2009 Q3 | 457.42 Thousand USD | 40.79% |
2009 Q1 | 64.74 Thousand USD | 117.54% |
2009 Q2 | 324.9 Thousand USD | 401.86% |
2009 FY | - USD | 152.21% |
2009 Q4 | 308.35 Thousand USD | -32.59% |
2008 Q1 | -875.28 Thousand USD | -380.65% |
2008 Q2 | -250.15 Thousand USD | 71.42% |
2008 Q3 | -742.21 Thousand USD | -196.7% |
2008 Q4 | -369.09 Thousand USD | 50.27% |
2008 FY | - USD | -1126.22% |
2007 FY | - USD | -63.17% |
2007 Q3 | 2773.00 USD | -95.54% |
2007 Q1 | -158.82 Thousand USD | -242.92% |
2007 Q2 | 62.13 Thousand USD | 139.12% |
2007 Q4 | 311.87 Thousand USD | 11146.84% |
2006 FY | - USD | -62.89% |
2006 Q4 | 111.12 Thousand USD | -19.71% |
2006 Q3 | 138.39 Thousand USD | -63.89% |
2006 Q2 | 383.28 Thousand USD | 1034.36% |
2006 Q1 | -41.02 Thousand USD | -111.97% |
2005 Q4 | 342.6 Thousand USD | -8.5% |
2005 Q3 | 374.41 Thousand USD | -28.93% |
2005 FY | - USD | -13.5% |
2005 Q1 | 350.94 Thousand USD | -20.16% |
2005 Q2 | 526.8 Thousand USD | 50.11% |
2004 Q4 | 439.55 Thousand USD | -11.37% |
2004 Q2 | 532.01 Thousand USD | 41.4% |
2004 Q3 | 495.94 Thousand USD | -6.78% |
2004 FY | - USD | 223.01% |
2004 Q1 | 376.24 Thousand USD | 440.14% |
2003 FY | - USD | -51.9% |
2003 Q2 | 216.37 Thousand USD | -26.59% |
2003 Q1 | 295.04 Thousand USD | -3.6% |
2003 Q4 | -104.62 Thousand USD | -163.35% |
2003 Q3 | 175.4 Thousand USD | -18.62% |
2002 Q3 | 303.82 Thousand USD | 22.94% |
2002 FY | - USD | -1.75% |
2002 Q4 | 312.55 Thousand USD | 0.19% |
2002 Q2 | 248.28 Thousand USD | -26.52% |
2002 Q1 | 337.3 Thousand USD | 0.02% |
2001 Q2 | 248.4 Thousand USD | -32.56% |
2001 Q3 | 270.25 Thousand USD | 8.09% |
2001 Q4 | 344.44 Thousand USD | 26.47% |
2001 FY | - USD | 36.54% |
2001 Q1 | 367.22 Thousand USD | -44.79% |
2000 Q2 | - USD | -100.0% |
2000 Q3 | 27.07 Thousand USD | 0.0% |
2000 FY | - USD | -50.85% |
2000 Q1 | 300 Thousand USD | 0.0% |
2000 Q4 | 667.72 Thousand USD | 4923.01% |
1999 Q2 | 300 Thousand USD | -62.5% |
1999 Q4 | 300 Thousand USD | -25.0% |
1999 FY | - USD | 38.46% |
1999 Q1 | 800 Thousand USD | 166.67% |
1999 Q3 | 400 Thousand USD | 33.33% |
1998 Q3 | 300 Thousand USD | 50.0% |
1998 FY | - USD | 225.0% |
1998 Q1 | 300 Thousand USD | -25.0% |
1998 Q2 | 200 Thousand USD | -33.33% |
1998 Q4 | 300 Thousand USD | 0.0% |
1997 Q4 | 200 Thousand USD | -20.0% |
1997 Q3 | 300 Thousand USD | 400.0% |
1997 Q1 | 300 Thousand USD | 200.0% |
1997 Q2 | 100 Thousand USD | -66.67% |
1997 FY | - USD | -55.56% |
1996 FY | - USD | 200.0% |
1996 Q4 | -200 Thousand USD | -400.0% |
1996 Q3 | 100 Thousand USD | -80.0% |
1996 Q2 | 300 Thousand USD | 600.0% |
1996 Q1 | -100 Thousand USD | 0.0% |
1995 FY | - USD | 133.33% |
1995 Q3 | 200 Thousand USD | 0.0% |
1995 Q2 | 300 Thousand USD | 100.0% |
1995 Q1 | 100 Thousand USD | 133.33% |
1995 Q4 | - USD | -150.0% |
1994 Q2 | 200 Thousand USD | 125.0% |
1994 Q1 | -800 Thousand USD | -900.0% |
1994 FY | - USD | -1000.0% |
1994 Q4 | -200 Thousand USD | -400.0% |
1994 Q3 | 100 Thousand USD | -50.0% |
1993 Q4 | 100 Thousand USD | -50.0% |
1993 Q1 | 100 Thousand USD | -66.67% |
1993 FY | - USD | -88.89% |
1993 Q2 | - USD | -100.0% |
1993 Q3 | 200 Thousand USD | 0.0% |
1992 Q3 | 200 Thousand USD | 0.0% |
1992 Q2 | 200 Thousand USD | 0.0% |
1992 Q1 | 200 Thousand USD | 0.0% |
1992 Q4 | 100 Thousand USD | 50.0% |
1992 FY | - USD | 80.0% |
1991 Q2 | 100 Thousand USD | -50.0% |
1991 Q1 | 200 Thousand USD | 100.0% |
1991 Q4 | 200 Thousand USD | 0.0% |
1991 Q3 | 200 Thousand USD | 100.0% |
1991 FY | - USD | -16.67% |
1990 Q2 | 1.6 Million USD | 6.67% |
1990 Q4 | 100 Thousand USD | -50.0% |
1990 FY | - USD | -33.33% |
1990 Q1 | 1.5 Million USD | 134.09% |
1990 Q3 | 200 Thousand USD | -87.5% |
1989 Q1 | 1.5 Million USD | 0.0% |
1989 Q2 | 1.8 Million USD | 20.0% |
1989 FY | - USD | 0.0% |
1989 Q4 | -4.4 Million USD | -309.52% |
1989 Q3 | 2.1 Million USD | 16.67% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acutus Medical, Inc. | -13.48 Million USD | 92.763% |
Biotricity, Inc. | -8.82 Million USD | 88.945% |
Cell MedX Corp. | - USD | Infinity% |
Nemaura Medical Inc. | -7.28 Million USD | 86.606% |
PetVivo Holdings, Inc. | -10.49 Million USD | 90.7% |
RetinalGenix Technologies Inc. | -2.08 Million USD | 53.233% |
Sonendo, Inc. | -54.76 Million USD | 98.218% |
Telesis Bio, Inc. | -40.49 Million USD | 97.59% |
Talis Biomedical Corporation | -66.04 Million USD | 98.522% |
Viveve Medical, Inc. | -20.61 Million USD | 95.266% |